Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,786
-$229,564 QoQ
Shares Held
64
-97.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#682
of 768 holders
Holding Since
Mar 2020
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026IFG Advisory, LLC holds $298,076 across 12 Drug Manufacturers - Specialty & Generic names. NBIX ranks #6 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,979 | $142,210 | |
| 2 | HLN |
Haleon plc
|
5,494 | $51,259 | |
| 3 | VTRS |
Viatris Inc
|
2,122 | $33,697 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
56 | $30,342 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
374 | $12,671 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
This page
|
64 | $10,786 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
250 | $9,050 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
300 | $7,611 |
All Filings in NBIX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,786 | 64 | Shares | Sole | 2026-08-14 | |
| 2021-09-30 | $240,350 | 2,506 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $240,672 | 2,473 | Shares | Sole | 2021-07-21 | |
| 2020-09-30 | $217,706 | 2,264 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $271,938 | 2,229 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $201,574 | 2,329 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||